Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH

K-Number: K903417 · 1990-12-05

ApplicantVas-Cath, Inc.
Decision Date1990-12-05
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH is the device name listed in this FDA 510(k) record. The listed applicant is Vas-Cath, Inc.. It received FDA 510(k) clearance on 1990-12-05 under 510(k) number K903417. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH?

VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH is a medical device that received FDA 510(k) clearance on 1990-12-05. The listed applicant is Vas-Cath, Inc.. The 510(k) number is K903417.

When did VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH receive FDA 510(k) clearance?

VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH received FDA 510(k) clearance on 1990-12-05, under 510(k) number K903417.

Who is the listed applicant for VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH?

The FDA 510(k) record lists Vas-Cath, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH?

The FDA product code for VAS-CATH OPTI-PLAST 5F PERIPHERAL ANGIOPLASTY CATH is LIT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Vas-Cath, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K973013OPTI-PLAST (CENTURION) 5.5F ANGIOPLASTY CATHETERK965178NIAGARA DUAL LUMEN CATHETERK964881ULTRAVERSE PTA CATHETERK970725OPTI-PLAST XL 5.5 F PTA CATHETERK941706OPTI-PLAST ANGIOPLASTY CATHETERK925485VAS-CATH INC. OPTI-PLAST ANGIOPLASTY CATHETER

View all 27 devices →

Related Devices (Code: LIT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260416ZYLOX Hippo PTA Balloon Dilatation CatheterZylox Medtech Co., Ltd.K254212NC PTA Balloon Dilatation CatheterKossel Medtech (Suzhou) Co., Ltd.K260304WAVE PTA Balloon CatheterWAVE Medical AGK252512Armada™ 14 NC PTA CatheterABBOTT MEDICALK251915Amethyst HP PTA OTW 0.035 CatheterNatec Medical , Ltd.K250706Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation Catheters; Passeo-14 Peripheral Dilatation Catheter; Oscar Peripheral Multifunctional Catheter System; Pantera Pro Percutaneous Transluminal Coronary Angioplasty Catheter; Pantera LEO Percutaneous Transluminal Coronary Angioplasty (PTCA) CatheterBiotronik, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑